Emergent BioSolutions (EBS) Net Margin (2011 - 2026)
Emergent BioSolutions (EBS) posted quarterly Net Margin of 4.36% for Q1 2026, down 2625.0% year-over-year from 0.17% in Q1 2025, and up 111.86% quarter-over-quarter from 36.72% in Q4 2025.
Emergent BioSolutions (EBS) Net Margin (2011 - 2026) Analysis & Trends
Emergent BioSolutions' Net Margin history runs 15 years deep, the most recent figure standing at 4.36% for Q1 2026.
- In Q1 2026, Net Margin fell 2625.0% year-over-year to 4.36%; the TTM figure through Mar 2026 stood at 1.27% (up 1603.0% YoY), while the FY2025 annual figure was 7.08%, up 2534.0% from the prior year.
- Net Margin for Q1 2026 stood at 4.36%, up from 36.72% in the prior quarter.
- The five-year high for Net Margin was 39.07% in Q3 2024, with the low at 566.2% in Q2 2024.
- The 5-year median for Net Margin is 17.9% (2023), against an average of 53.84%.
- The sharpest annual moves came in 2024 and 2025: Net Margin slumped 48884 bps in 2024, then jumped 55768 bps in 2025.
- Emergent BioSolutions' Net Margin stood at 20.29% in 2022, then climbed by 12 bps to 17.9% in 2023, then climbed by 10 bps to 16.08% in 2024, then plunged by 128 bps to 36.72% in 2025, then soared by 112 bps to 4.36% in 2026.
- Business Quant data shows EBS's Net Margin at 4.36% in Q1 2026, 36.72% in Q4 2025, and 22.15% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn | -76.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -76.91% |
| Mar 31, 2026 | 4.36% |
| Dec 31, 2025 | -36.72% |
| Sep 30, 2025 | 22.15% |
| Jun 30, 2025 | -8.52% |
| Mar 31, 2025 | 30.60% |
| Dec 31, 2024 | -16.08% |
| Sep 30, 2024 | 39.07% |
| Jun 30, 2024 | -566.20% |
| Mar 31, 2024 | 3.00% |
| Dec 31, 2023 | -17.90% |
| Sep 30, 2023 | -97.38% |
| Jun 30, 2023 | -77.36% |
| Mar 31, 2023 | -113.33% |
| Dec 31, 2022 | -20.29% |
| Sep 30, 2022 | -36.31% |
| Jun 30, 2022 | -23.25% |
| Mar 31, 2022 | -1.21% |
| Dec 31, 2021 | 24.27% |
| Sep 30, 2021 | -11.42% |